scispace - formally typeset
A

Anders Sönnerborg

Researcher at Karolinska Institutet

Publications -  432
Citations -  21283

Anders Sönnerborg is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Viral load & Virus. The author has an hindex of 66, co-authored 407 publications receiving 19240 citations. Previous affiliations of Anders Sönnerborg include University of Missouri & University College London.

Papers
More filters
Journal ArticleDOI

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries.

TL;DR: MddNR resistant HIV-1 can be found in European patients and is characterized by a specific set of drug resistance mutations, cross-resistance to most ddN analogues and a fast clinical progression.
Journal Article

Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.

TL;DR: These results indicate that combination treatment with interferon alfa-2b and ribavirin offers a chance of sustained biochemical response and virus eradication in a subset of patients who fail to achieve sustained response to interferons alfa alone.
Journal ArticleDOI

Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells.

TL;DR: In comparison to monocytes, LPS stimulation of DC generated a lower incidence of TNF-alpha, IL-6,IL-10 and IL-12 producing cells while IL-1 was expressed in a comparable number of cells, while all the other cytokines were undetectable.
Journal ArticleDOI

Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection.

TL;DR: Findings demonstrate that there was a broad and early immune activation in GALT and pLT during acute HIV-1 infection, and questions the functional efficacy of the observed immuneactivation in generating cytotoxic T cells that were able to eliminate HIV-infected cells.
Journal ArticleDOI

HIV viral load and response to antileishmanial chemotherapy in co-infected patients.

TL;DR: It is suggested that pre-treatment HIV viral load influences response to anti-leishmanial chemotherapy and active VL is associated with increased viral replication in vivo, supporting the notion that dual infection plays an important role in the pathogenesis and disease progression of either infection.